SIRT3 and gastric cancer: Molecularly, in GC cell lines, SIRT3 has been shown to repress Notch1, inhibiting its negative regulation of cell proliferation [97,98], to repress HIF1α [99,101], and to interact with lactate dehydrogenase A (LDHA), thereby increasing its activity and ROS homeostasis [100].